Multiomics
)
Reveal more biology in a single assay
Multiomic studies utilise multiple omics methods — including genomics, transcriptomics, epigenomics, and proteomics — to gain a more comprehensive understanding of complex biology in health and disease. Combining various omics data types empowers researchers to create comprehensive disease models and enhance biomarker discovery.
Traditional multiomics approaches require multiple assays, platforms, and data analyses, resulting in complex and time-consuming workflows. Now, Oxford Nanopore sequencing enables genomic, epigenomic, and transcriptomic — including single-cell, spatial, bulk, and targeted — analysis with any-length reads using streamlined workflows on a single platform.
Oxford Nanopore technology generates ultra-rich multiomic sequencing data to shed light on complex biology, including single nucleotide variants (SNVs), structural variants (SVs), copy number variants (CNVs), short tandem repeats (STRs), haplotypes, and methylation — in one go.
Featured content
Multiomic nanopore sequencing
Resolving the mechanisms underpinning human diseases is vital to understand disease phenotypes, identify novel biomarkers, and enable drug discovery. Find out how the application of multiomic nanopore sequencing is revolutionising human disease research.
Taking multiomics to new lengths with Oxford Nanopore
Jonathan Mill (University of Exeter Medical School, UK) looks beyond DNA sequence variation to better understand complex diseases, with a focus on the central nervous system. Discover why he uses nanopore sequencing to uncover data missed with short-read sequencing.
Related content
Recommended device for multiomic sequencing
)
PromethION 24
Flexible, population-scale sequencing using up to 24 independently addressable, high-capacity flow cells — ideal for complete genomic, transcriptomic, and epigenomic characterisation of large sample numbers.
